Zoetis (ZTS) FY2016 results: revenue $4.9 billion, up 2.6% on the year
Zoetis Inc. (ZTS) reported revenue of $4.9 billion for fiscal 2016, the year ended 31 December 2016, up 2.6% on the year before. Net income was $821 million, up 142.2%, and diluted earnings per share $1.65. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2019.
Revenue
$4.9 billion
+2.6% on the year
FY2011FY2016
Operating margin
n/a
FY2011FY2016
Net income
$821 million
+142.2% on the year
FY2011FY2016
Diluted EPS
$1.65
+142.6% on the year
FY2011FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
4,888
4,765
4,785
+2.6%
Cost of revenue
1,666
1,738
1,717
-4.1%
Gross profit
3,222
3,027
3,068
+6.4%
Gross margin
65.9%
63.5%
64.1%
Research and development
376
364
396
+3.3%
Selling, general and administrative
1,364
1,532
1,643
-11.0%
Interest expense
166
124
117
+33.9%
Pre-tax income
1,228
545
820
+125.3%
Income tax
409
206
233
+98.5%
Effective tax rate
33.3%
37.8%
28.4%
Net income
821
339
583
+142.2%
Net margin
16.8%
7.1%
12.2%
Diluted EPS
$1.65
$0.68
$1.16
+142.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
713
664
626
+7.4%
Capital expenditure
216
224
180
-3.6%
Free cash flow
497
440
446
+13.0%
Free cash flow margin
10.2%
9.2%
9.3%
Cash from investing
-214
-1,115
-187
Cash from financing
-903
755
-154
Depreciation and amortisation
240
199
204
+20.6%
Share-based compensation
37.0
43.0
32.0
-14.0%
Buybacks
300
203
0.0
+47.8%
Dividends paid
188
168
146
+11.9%
Dividend per share
$0.39
$0.34
$0.30
+13.4%
Diluted shares, weighted
498m
502m
502m
-0.8%
Shares outstanding at period end
493m
497m
501m
-0.9%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
1,487
1,068
1,311
+39.2%
Non-controlling interest
12.0
23.0
26.0
-47.8%
Debt
4,468
4,863
3,624
-8.1%
Other liabilities
1,682
1,959
1,627
-14.1%
Total liabilities and equity
7,649
7,913
6,588
-3.3%
Fixed assets
1,381
1,307
1,318
+5.7%
Goodwill
1,481
1,455
976
+1.8%
Intangible assets
1,228
1,190
727
+3.2%
Cash and equivalents
727
1,154
882
-37.0%
Receivables
913
937
980
-2.6%
Inventory
1,502
1,467
1,289
+2.4%
Other assets
417
403
416
+3.5%
Total assets
7,649
7,913
6,588
-3.3%
10-K for the year ended 31 December 2016, filed 14 February 2019: the filing.